Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein
- PMID: 10594550
- PMCID: PMC1905457
- DOI: 10.1046/j.1365-2249.1999.00939.x
Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein
Abstract
Two amyloidogenic Bence Jones proteins (Am37 VkappaIV and NIG1 VkappaI) and one non-amyloidogenic protein (NIG26 VkappaIII) were characterized. The protein Am37 had four deletions when compared with the translated germ-line gene sequence: two Ser residues following position 27 (27e, 27f) in CDR1 and two amino acids Pro-44, and Tyr-49 in FR2 were deleted. A strictly conserved salt-bridge-forming amino acid, Asp-82, was replaced by the hydrophobic residue Leu. In a comparative study of amyloidogenic and non-amyloidogenic proteins, five amino acids (Ser-10, Ala-13, Ser-65, Gln-90, and Ile-106) were found to be unique to NIG1 and several other amyloidogenic proteins. Additional substitutions also occur within these proteins. These substitutions might be significant in altering protein folding as well as in contributing to their aggregation as amyloid fibrils.
Figures



Similar articles
-
Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).Amyloid. 1999 Jun;6(2):77-88. doi: 10.3109/13506129909007307. Amyloid. 1999. PMID: 10439113
-
Structural relationship of lambda-type light chains with AL amyloidosis.Clin Immunol. 1999 Mar;90(3):399-403. doi: 10.1006/clim.1998.4662. Clin Immunol. 1999. PMID: 10075869
-
Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.Scand J Immunol. 1998 Jul;48(1):92-8. doi: 10.1046/j.1365-3083.1998.00352.x. Scand J Immunol. 1998. PMID: 9714416
-
ALkappa(I) (UNK) - primary structure of an AL-amyloid protein presenting an organ-limited subcutaneous nodular amyloid syndrome of long duration. Case report and review.Amyloid. 2010 Mar;17(1):10-23. doi: 10.3109/13506121003619328. Amyloid. 2010. PMID: 20146644 Review.
-
A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis.QJM. 1995 Oct;88(10):695-702. QJM. 1995. PMID: 7493166 Review.
Cited by
-
Structural alterations within native amyloidogenic immunoglobulin light chains.J Mol Biol. 2009 May 29;389(1):199-210. doi: 10.1016/j.jmb.2009.04.010. Epub 2009 Apr 8. J Mol Biol. 2009. PMID: 19361523 Free PMC article.
-
A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.Structure. 2010 May 12;18(5):563-70. doi: 10.1016/j.str.2010.02.012. Structure. 2010. PMID: 20462490 Free PMC article.
-
Deposition-associated diseases related with a monoclonal compound.Clin Transl Oncol. 2007 Dec;9(12):777-83. doi: 10.1007/s12094-007-0139-8. Clin Transl Oncol. 2007. PMID: 18158981 Review.
-
Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.Int J Cell Biol. 2013;2013:604867. doi: 10.1155/2013/604867. Epub 2013 Mar 5. Int J Cell Biol. 2013. PMID: 23533417 Free PMC article.
-
Hepatocyte-derived Igκ promotes HCC progression by stabilizing electron transfer flavoprotein subunit α to facilitate fatty acid β-oxidation.J Exp Clin Cancer Res. 2024 Oct 9;43(1):280. doi: 10.1186/s13046-024-03203-8. J Exp Clin Cancer Res. 2024. PMID: 39380077 Free PMC article.
References
-
- Glenner GG, Terry W, Harada M, Isersky C, Page D. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analysis. Science (Wash DC) 1971;172:1150–1. - PubMed
-
- Glenner GG. Amyloid deposits and amyloidosis. The β-fibrillosis. N Engl J Med. 1980;302:1283–92. 1333–43. - PubMed
-
- Kabat EA, Wu TT, Reid-Miller M, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest. Bethesda, MD: Natl Inst Health; 1994. pp. 165–462.
-
- Stone MJ. Amyloidosis: a final common pathway for protein deposition in tissues. Blood. 1990;75:531–45. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical